Neogen (NEOG) Share-based Compensation Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Neogen | 1.94 Bn | 1.78 Bn | 99.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -7.00% |
| Nov 30, 2025 | 23.48% |
| Aug 31, 2025 | 24.17% |
| May 31, 2025 | 20.73% |
| Feb 28, 2025 | 20.69% |
| Nov 30, 2024 | 24.49% |
| Aug 31, 2024 | 20.88% |
| May 31, 2024 | 22.88% |
| Feb 29, 2024 | 23.01% |
| Nov 30, 2023 | 20.19% |
| Aug 31, 2023 | 13.01% |
| May 31, 2023 | 18.69% |
| Feb 28, 2023 | 22.34% |
| Nov 30, 2022 | 15.78% |
| Aug 31, 2022 | 5.91% |
| May 31, 2022 | 9.68% |
| Feb 28, 2022 | 6.05% |
| Nov 30, 2021 | 7.49% |
| Aug 31, 2021 | 2.20% |
| May 31, 2021 | 2.64% |
| Feb 28, 2021 | 1.58% |
| Nov 30, 2020 | 3.90% |
| Aug 31, 2020 | 5.32% |
| May 31, 2020 | 5.78% |
| Feb 29, 2020 | 5.96% |
| Nov 30, 2019 | 8.89% |
| Aug 31, 2019 | 11.21% |
| May 31, 2019 | -1.13% |
| Feb 28, 2019 | 5.63% |
| Nov 30, 2018 | 9.09% |
| Aug 31, 2018 | 12.65% |
| May 31, 2018 | 7.04% |
| Feb 28, 2018 | 5.34% |
| Nov 30, 2017 | 11.81% |
| Aug 31, 2017 | 15.49% |
| May 31, 2017 | 13.75% |
| Feb 28, 2017 | 11.83% |
| Nov 30, 2016 | 20.88% |
| Aug 31, 2016 | 20.37% |
| May 31, 2016 | 28.75% |
| Feb 29, 2016 | 20.15% |
| Nov 30, 2015 | 17.22% |
| Aug 31, 2015 | 13.95% |